| | | | |
CUSIP No. 39957D201 | | 13G | | Page 7 of 9 Pages |
Introductory Note: This Amendment No. 2 (the “Amendment”) amends and supplements the Schedule 13G originally filed by the Reporting Persons with the Commission on August 5, 2022, as amended by Amendment No. 1 filed with the Commission on February 9, 2023 (collectively, the “Original Schedule 13G”). Only those items that are hereby reported are amended; all other items reported in the Original Schedule 13G remain unchanged. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable. Capitalized terms not defined in this Amendment have the meanings ascribed to them in the Original Schedule 13G.
Item 1(b). Address of Issuer’s Principal Executive Offices:
1301 Sansome Street
San Francisco, CA 94111
Item 2(b) Address of Principal Business Office, or if None, Residence:
The address of the principal business office of each Reporting Person is 22 Boston Wharf Road, 7th Floor, Boston, MA 02210.
Item 2(e). CUSIP Number:
39957D201
Item 4. Ownership.
| (a) | Amount beneficially owned: |
See Row 9 of the cover page for each Reporting Person. As the general partner of each of NextView II and NextView II-A, NextView GP II may be deemed to beneficially own the shares held by each of NextView II and NextView II-A. As the general partner of NextView Co-Invest, NextView GP Co-Invest may be deemed to beneficially own the shares held by NextView Co-Invest.
See Row 11 of the cover page for each Reporting Person.
(c) | Number of shares as to which the person has: |
(i) | Sole power to vote or to direct the vote |
See Row 5 of the cover page for each Reporting Person.*
(ii) | Shared power to vote or to direct the vote |
See Row 6 of the cover page for each Reporting Person.*
(iii) | Sole power to dispose or to direct the disposition of |
See Row 7 of the cover page for each Reporting Person.*
(iv) | Shared power to dispose or to direct the disposition of |
See Row 8 of the cover page for each Reporting Person.*